Celldex Therapeutics Inc. (CLDX) tumbled -6.48% or -0.05 to $0.72. It is close to 2.66 million shares traded, which is 62.44% compare to the average total volume 4.25 million. The market cap of CLDX is $103.40 million. The year to date change is -73.59%. The 52 week price range is from $0.65 to $3.27. Price of CLDX have changed -2.40% during last week. It have changed -62.75% over last month, -67.60% over last 3 months, -71.75% over last 6 months and -75.60% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 1.81. It is 151.39% above current price. The 200-day Moving Averages for CLDX is 2.47. It is 243.06% above current price. The 52-week High is 3.27. It is 354.17% from the current price. The 52-week Low is 0.65. It is -9.72% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLDX is 7.18 on 2018-04-13. Short % to float is 7.64%. There are some statistics of CLDX. It is has market cap $103.40 million. The share outstanding is 143.39 million. The average volume is 4.25 million. The revenue is 9.29M. The percent of top 15 Institution holding is 49.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -34.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -24.71%.